Basel Medical Group Ltd (BMGL) News & EventsBMGLBasel Medical Group Ltd

Basel Medical Group Issues 6 Million Units at $1.33 Each

Basel Medical Group entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent, as well as a securities purchase agreement with certain purchasers, pursuant to which the company will issue and sell 6,000,000 units, at a public offering price of $1.33 per Unit, each consisting of one ordinary share with no par value or one Pre-Funded Warrant of the company, and one warrant, each to purchase one Ordinary Share. The Ordinary Shares are listed on the Nasdaq Capital Market under the symbol "BMGL". The Common Warrants and Pre-Funded Warrants will not be listed or quoted on any exchange. The total gross proceeds to the company from the offering, before deducting commissions and offering expenses, will be $7.98M. The company estimates that its net proceeds from this offering will be approximately $7.28M. The company and all of its executive officers, directors and certain shareholders beneficially owning 5.0% or more of the ordinary shares prior to this offering have entered into lock-up agreements in connection with the offering.

Basel Medical Group Ltd Trading Halted Due to Volatility

Basel Medical Group Ltd trading halted, volatility trading pause

Basel Medical Group Ltd Trading Halted

Basel Medical Group Ltd trading halted, volatility trading pause